To further investigate how this aberrant expression contributes to tumorigenesis, we performed an RNA-seq analysis of MEN1 shRNA knockdown in two ERα-positive breast cancer cell lines T47D and MCF-7, respectively (Figure 1A,B). This evidence concerns the gene MEN1 and breast cancer.